Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Huriez syndrome and SCC risk: a narrative review highlighting surgical challenges and oncologic considerations

Title: Huriez syndrome and SCC risk: a narrative review highlighting surgical challenges and oncologic considerations
Authors: Pagnotta A.; Patane L.; Zoccali C.; Loria F. S.; Lo Torto F.; Ribuffo D.
Contributors: Pagnotta, A.; Patane, L.; Zoccali, C.; Loria, F. S.; Lo Torto, F.; Ribuffo, D.
Publisher Information: MDPI; Basel
Publication Year: 2025
Collection: Sapienza Università di Roma: CINECA IRIS
Subject Terms: huriez syndrome; genodermatose; rare disease; skin cancer; squamous cell carcinoma
Description: Background: Huriez syndrome is a rare hereditary skin disorder marked by early-onset sclerodactyly, hyperkeratosis of the palms and soles, and nail dysplasia. A key concern is the early and aggressive development of cutaneous squamous cell carcinoma (SCC), typically affecting the dorsal aspects of the hands. Methods: This narrative review summarizes clinical features, genetic aspects, and oncologic implications of Huriez syndrome. A systematic search was conducted in PubMed and Scopus, including English-language articles published up to May 2025. Relevant case reports and small case series were analyzed. Results: Seven patients (58.3%) underwent multiple surgeries due to recurrent or bilateral disease. Six patients (50%) required amputations, including finger, hand, and arm amputations, with no foot amputations reported. Reconstruction after oncological resection was performed in six patients (50%) using skin grafts (3), pedicled flaps (2), or free flaps (1). Amputation was mainly for advanced disease, with radial forearm flaps used for reconstruction. All flaps remained disease-free. Five cases (41.6%) had a history of local recurrence. Conclusions: The early diagnosis of Huriez syndrome is crucial to enable the surveillance and timely treatment of SCC. A multidisciplinary team including dermatologists, oncologists, plastic surgeons, and geneticists is recommended. Further research is needed to clarify genetic mechanisms and develop early detection strategies to improve outcomes.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/40806836; info:eu-repo/semantics/altIdentifier/wos/WOS:001548812600001; volume:14; issue:15; firstpage:1; lastpage:10; numberofpages:10; journal:JOURNAL OF CLINICAL MEDICINE; https://hdl.handle.net/11573/1751355
DOI: 10.3390/jcm14155214
Availability: https://hdl.handle.net/11573/1751355; https://doi.org/10.3390/jcm14155214
Rights: info:eu-repo/semantics/openAccess ; license:Creative commons ; license uri:http://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.A08EA51E
Database: BASE